Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma
Open Access
- 12 February 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (7), 1168-1173
- https://doi.org/10.1038/sj.bjc.6690186
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells.1997
- Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.1996
- Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.1996
- Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.The Journal of cell biology, 1995
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.The Journal of cell biology, 1995
- Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.The Journal of Experimental Medicine, 1993
- Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.The Journal of Experimental Medicine, 1991
- Purification and partial characterization of CD9 antigen of human plateletsFEBS Letters, 1990
- Retrosternal Esophagogastrostomy with the EEA Stapler after Subtotal Resection of the Esophagus: Application and ResultsDigestive Surgery, 1987